GPC3 and hepatocellular carcinoma: Vaccine approaches may target peptides known to be present in HCC (e.g., AFP, GPC-3, MAGE-1, NY-ESO-1, SSX-2, and hTERT) or can be personalized for individual patients by targeting neoantigens.